Sequenom, Inc. (SQNM) - Financial and Strategic SWOT Analysis Review

Date: May 7, 2013
Pages: 49
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: SE695784157EN
Leaflet:

Download PDF Leaflet

Sequenom, Inc. (SQNM) - Financial and Strategic SWOT Analysis Review
Summary

Sequenom, Inc. (Sequenom) is a molecular diagnostic testing and genetics analysis company. It carries out the development and manufacture of DNA analysis systems and related consumables and reagent kits for fine mapping genotyping applications, biomedical research, agricultural applications, molecular medicine and non-invasive prenatal diagnostics research. The company’s major product is MassARRAY system, a proprietary nucleic acid analysis platform. The company operates across the Americas, Asia and Europe. Sequenom is headquartered in California, the US.

Sequenom, Inc. Key Recent Developments

Mar 07, 2013: Sequenom Reports Revenue Of $89.7m In 2012
Dec 14, 2012: Sequenom Provides Update On Status Of Patent For Methods Of Detecting Fetal Aneuploidy
Dec 11, 2012: Sequenom Appoints William Welch As COO
Dec 06, 2012: Sequenom Announces Issuance Of Patent For Methods Of Detecting Fetal Aneuploidy
Nov 08, 2012: Sequenom Reports Revenue Of $22.9m In Q3 2012

This comprehensive SWOT profile of Sequenom, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY

Sequenom, Inc. - Key Facts
Sequenom, Inc. - Key Employees
Sequenom, Inc. - Key Employee Biographies
Sequenom, Inc. - Major Products and Services
Sequenom, Inc. - Medical Equipment Pipeline Products Data
Sequenom, Inc. Pipeline Products by Equipment Type
Sequenom, Inc. Pipeline Products by Development Stage
Sequenom, Inc. - History
Sequenom, Inc. - Company Statement
Sequenom, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Sequenom, Inc. - Business Description
Sequenom, Inc. - SWOT Analysis
SWOT Analysis - Overview
Sequenom, Inc. - Strengths
Strength - Proprietary MassARRAY System
Strength - Research and Development Activities
Strength - Synergies through Acquisitions
Sequenom, Inc. - Weaknesses
Weakness - Operational Inefficiency
Sequenom, Inc. - Opportunities
Opportunity - New Products
Opportunity - Strategic Agreements
Opportunity - Growing Aged Population
Sequenom, Inc. - Threats
Threat - Changing Diagnostic Market Conditions
Threat - Uncertain R&D Outcomes
Threat - Stringent Government Regulations
Sequenom, Inc. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Sequenom, Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013
Sequenom, Inc., Medical Equipment, Deals By Type, 2007 to YTD 2013
Sequenom, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Sequenom, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Sequenom, Inc., Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Sequenom, Inc., Recent Developments
Apr 16, 2013: Sequenom CMM Achieves Milestone Of 100,000 MaterniT21 Plus Tests Processed
Mar 21, 2013: Sequenom Announces Availability Of Heredi-T Cystic Fibrosis Carrier Screening LDT Through Sequenom CMM
Mar 07, 2013: Sequenom Reports Revenue Of $89.7m In 2012
Dec 14, 2012: Sequenom Provides Update On Status Of Patent For Methods Of Detecting Fetal Aneuploidy
Dec 11, 2012: Sequenom Appoints William Welch As COO
Dec 06, 2012: Sequenom Announces Issuance Of Patent For Methods Of Detecting Fetal Aneuploidy
Nov 08, 2012: Sequenom Reports Revenue Of $22.9m In Q3 2012
Aug 28, 2012: Sequenom Completes International Distribution Agreements To Expand Access To MaterniT21 PLUS Prenatal Testing Service
Jul 26, 2012: Sequenom Reports Revenue Of $18.3 In Q2 2012
Jul 06, 2012: Sequenom Addresses Preliminary Injunction Decision, Reaffirms Defense Of Patent

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Sequenom, Inc., Key Facts
Sequenom, Inc., Key Employees
Sequenom, Inc., Key Employee Biographies
Sequenom, Inc., Major Products and Services
Sequenom, Inc. Number of Pipeline Products by Equipment Type
Sequenom, Inc. Pipeline Products by Equipment Type
Sequenom, Inc. Number of Pipeline Products by Development Stage
Sequenom, Inc. Pipeline Products by Development Stage
Sequenom, Inc., History
Sequenom, Inc., Other Locations
Sequenom, Inc., Subsidiaries
Sequenom, Inc., Key Competitors
Sequenom, Inc., Ratios based on current share price
Sequenom, Inc., Annual Ratios
Sequenom, Inc., Interim Ratios
Sequenom, Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013
Sequenom, Inc., Medical Equipment, Deals By Type, 2007 to YTD 2013
Sequenom, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Sequenom, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Sequenom, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

CryoLife, Inc. Pipeline Products by Equipment Type
CryoLife, Inc. Pipeline Products by Development Stage
CryoLife, Inc., Performance Chart (2008 - 2012)
CryoLife, Inc., Ratio Charts
CryoLife, Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013
CryoLife, Inc., Medical Equipment, Deals by Type, 2007 to YTD 2013

Ask Your Question

Sequenom, Inc. (SQNM) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: